Showing results (61-70 of 117) with videos related to
Sort By:
Pageof 12
Cancer Cell|April 12, 2017
Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer ProgressionAshleigh R Poh, Christopher G Love, Frederick Masson, et al.Nature Communications|July 23, 2024
Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escapeXinyu Wu, Margareta Go, Julie V Nguyen, et al.Brain Research|December 3, 2014
Dual role of Src kinase in governing neuronal survivalM Iqbal Hossain, Ashfaqul Hoque, Guillaume Lessene, et al.Plos Pathogens|September 5, 2025
Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversityXinyu Wu, Shane M Devine, Margareta Go, et al.Plos Biology|May 2, 2024
Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosisZheng Yuan, Mark F van Delft, Mark Xiang Li, et al.Antimicrobial Agents and Chemotherapy|February 18, 2010
Inhibitors of Leishmania GDP-mannose pyrophosphorylase identified by high-throughput screening of small-molecule chemical libraryKurt Lackovic, John P Parisot, Nerida Sleebs, et al.Journal of Medicinal Chemistry|April 27, 2021
Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-XL and BCL-2Michael J Roy, Amelia Vom, Toru Okamoto, et al.The EMBO Journal|November 25, 2020
BCL-XL exerts a protective role against anemia caused by radiation-induced kidney damageKerstin Brinkmann, Paul Waring, Stefan P Glaser, et al.Biochemical Pharmacology|September 6, 2011
M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastropheBenny J Evison, Mile Pastuovic, Rebecca A Bilardi, et al.Nature Communications|June 5, 2019
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutationsRichard W Birkinshaw, Jia-Nan Gong, Cindy S Luo, et al.Pageof 12